FBInvestor
Stocks / Sarepta Therapeutics Inc
Institutional Ownership

Sarepta Therapeutics Inc

CUSIP 803607AD2NOTE 1.250% 9/1SRPTQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon